Atlas Trials

Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load

Clinical trial NCT01933594 · COMPLETED

Trial details

NCT number
NCT01933594
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2014-05-05
Primary completion
2018-04-16
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.